This was previously reported, as well as the other five (qTOT2, qTOT15, qTOT12, qTOT19, and qTOT7).
The identified pathways contained both known biochemical transformations previously reported as well as other alternative pathways.
April orders were previously reported as $450 million.
In April, credit rose by $7.76 billion, previously reported as an increase of $8.9 billion.
Analysts expected consumer credit to rise $8.1 billion in December after November's gain, previously reported as $19.8 billion.
Imports of goods and services grew at a revised 8.7percentt annual rate, previously reported as a 10percentt pace.
In January, spending rose a revised 2.2percentto to a $747.6 billion annual rate, previously reported as a 2.7percentt gain.
Credit card and other revolving debt rose $6.5 billion, after a $3.5 billion increase in June, previously reported as a $3.8 billion gain.
Analysts had forecast import prices would rise 1.3percentt after a revised 1.1percentt rise in April, previously reported as a 1.6percentt increase.
Secoiridoid 1 has been previously reported as a c-MET inhibitor.
Both conformers have been previously reported as being the global minimum for this pentapeptide.
